Vivos Therapeutics, Inc. SEC filings VVOS

Vivos Therapeutics, Inc. has 301 filings in SEC EDGAR's recent list, going back to Sep 28, 2017. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Nov 2, 2026 —
DEF 14A Proxy statement Oct 29, 2026 Oct 29, 2026
PRE 14A Preliminary proxy statement Oct 19, 2026 Oct 19, 2026
DEF 14A Proxy statement Sep 29, 2025 Sep 26, 2025
DEFA14A Additional proxy material Nov 6, 2024 —
DEF 14A Proxy statement Oct 7, 2024 Oct 7, 2024
DEFA14A Additional proxy material Sep 14, 2023 —
DEFA14A Additional proxy material Sep 6, 2023 —
DEF 14A Proxy statement Aug 28, 2023 Aug 28, 2023
PRE 14A Preliminary proxy statement Aug 16, 2023 Aug 16, 2023
DEF 14A Proxy statement Jul 14, 2022 Jul 14, 2022
DEF 14A Proxy statement Jun 29, 2021 Jun 29, 2021

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
VVOS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Littleton, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1716166
Former names
Vivos BioTechnologies, Inc. (until Sep 29, 2017)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.